68 Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study
Radiology · 01.05.2023 · 307 (3)
DOI: 10.1148/radiol.222052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology, erschienen am 01.05.2023. Verfasst von Yaping Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Nuclear Medicine (Y.L., Q.P., F.L.), Department of Rheumatology and Clinical Immunology, National Clinical Research Center for…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Quinolines. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Chinese Academy of Medical, National High Level Hospital Clinical Research Funding, Chinese Society of Clinical Oncology Pilot Oncology Research Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Nuclear Medicine (Y.L., Q.P., F.L.), Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases, the Ministry of Education Key…
ORCID-Profile: Yaping Luo, Qingqing Pan, Min Li, Fang Li
Förderung
- Chinese Academy of Medical
- National High Level Hospital Clinical Research Funding
- Chinese Society of Clinical Oncology Pilot Oncology Research Fund
Zitieren
APA
Luo, Y., Pan, Q., Zhou, Z., Li, M., Wei, Y., Jiang, X., Yang, H., & Li, F. (2023). 68 Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study. Radiology, 307(3). https://doi.org/10.1148/radiol.222052
Vancouver
Luo Y, Pan Q, Zhou Z, Li M, Wei Y, Jiang X, et al. 68 Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study. Radiology. 2023;307(3). doi:10.1148/radiol.222052
BibTeX
@article{Luo2023,
author = {Luo, Yaping and Pan, Qingqing and Zhou, Ziyue and Li, Min and Wei, Yanping and Jiang, Xu and Yang, Huaxia and Li, Fang},
title = {68 Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study},
journal = {Radiology},
year = {2023},
volume = {307},
number = {3},
doi = {10.1148/radiol.222052}
}
EUVIMED